Cargando…
Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis
INTRODUCTION: Despite the theory that long-acting injectable (LAI) antipsychotics should be more likely to improve adherence, reduce gaps in therapy, and prevent relapse compared with oral antipsychotics, there is little published evidence on this issue, specifically in patients with early psychosis...
Autores principales: | Titus-Lay, Erika N., Ansara, Elayne D., Isaacs, Alex N., Ott, Carol A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007741/ https://www.ncbi.nlm.nih.gov/pubmed/29955546 http://dx.doi.org/10.9740/mhc.2018.03.056 |
Ejemplares similares
-
Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
por: Leighty, Anne E., et al.
Publicado: (2019) -
Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review
por: Lian, Lulu, et al.
Publicado: (2022) -
Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
por: Vasiliu, O.
Publicado: (2022) -
Extent of use of long-acting injectable antipsychotics in children and adolescents within Indiana Medicaid
por: Modesitt, Taylor, et al.
Publicado: (2018) -
Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa
por: Roopun, Krishanand R., et al.
Publicado: (2020)